SKF89976A盐酸盐结构式
|
常用名 | SKF89976A盐酸盐 | 英文名 | 1-(4,4-diphenyl-3-butenyl)-3-piperidinecarboxylicacidhydrochloride;SKF89976AHCl |
|---|---|---|---|---|
| CAS号 | 85375-15-1 | 分子量 | 371.90000 | |
| 密度 | N/A | 沸点 | 531.4ºC at 760 mmHg | |
| 分子式 | C22H26ClNO2 | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | 275.2ºC |
SKF89976A盐酸盐用途SKF89976A hydrochloride 是一种选择性 GABA 转运蛋白 GAT-1 抑制剂,作用于 CHO 细胞中的 GAT-1,GAT-2 和 GAT-3,IC50 分别为 0.28 μM,137.34 μM 和 202.8 μM。 |
| 中文名 | 1-(4,4-二苯基-3-丁烯基)-3-哌啶盐酸盐 |
|---|---|
| 英文名 | 1-(4,4-diphenylbut-3-enyl)piperidine-3-carboxylic acid,hydrochloride |
| 中文别名 | 1-(4,4-二苯基-3-丁烯基)-3-哌啶盐酸盐 | 1-(4,4-二苯基-3-丁烯)-3-哌啶羧酸盐酸盐 | 1-(4,4-二苯基-3-丁烯-1-基)-3-哌啶甲酸盐酸盐 |
| 英文别名 | 更多 |
| 描述 | SKF89976A hydrochloride 是一种选择性 GABA 转运蛋白 GAT-1 抑制剂,作用于 CHO 细胞中的 GAT-1,GAT-2 和 GAT-3,IC50 分别为 0.28 μM,137.34 μM 和 202.8 μM。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
IC50: 0.28 μM (GAT-1), 137.34 μM (GAT-2), 202.8 μM (GAT-3)[1] |
| 体外研究 | SKF89976A具有弱的抗异常疼痛作用。 SKF89976A在使用底物摄取试验稳定表达每种转运蛋白的中国仓鼠卵巢(CHO)细胞中弱抑制5-羟色胺转运蛋白(SERT),去甲肾上腺素转运蛋白(NET)和多巴胺转运蛋白(DAT),IC50值为3514,202.13和728.8,分别[1]。 SKF89976A是一种GABA转运阻断剂。 GABA(1 mM)引发内向电流,其被GABA转运抑制剂tiagabine(10μM)和SKF89976A(100μM)完全抑制,但不受100μM印防己毒素的影响。已知100μMSKF89976-A阻断GABA向细胞的转运,以可逆的方式完全消除GABA引发的电流[2]。 SKF89976A是GAT-1的非运输阻滞剂。 SKF89976-A还抑制可能由背景GABA激活强直性GAT引起的基线内向电流。 SKF89976A(100μM)可逆地将每个研究细胞中的GAT电流降低67.9±4.4%(n = 19)。细胞内灌注20μMSKF89976-A逐渐减少和阻断GABA诱导的GAT电流而不阻断GABAAR介导的电流(n = 4)[3]。 |
| 体内研究 | 当静脉内给药(0.3mg/kg)时,SKF89976A产生弱的抗异常性疼痛反应。注射SKF89976A可剂量依赖性地改善PSL模型小鼠戒断阈值的降低[1]。 |
| 细胞实验 | 将稳定表达小鼠GAT亚型,大鼠5-羟色胺转运蛋白(SERT),大鼠去甲肾上腺素转运蛋白(NET)和大鼠多巴胺转运蛋白(DAT)的CHO细胞与10nM氚标记的GABA或单胺在不存在或不存在下孵育10分钟。测试了各种浓度的GAT抑制剂(例如,SKF89976A)。 SERT,NET和DAT的值是3次实验的平均值±SEM,每次都是一式两份进行[1]。 |
| 动物实验 | 使用小鼠[1]在研究开始时体重25-30g的5周龄ddY雄性小鼠。给予小鼠NNC05-2090,SKF89976A(0.3mg / kg,ip),(S)-SNAP5114或阿米替林。 ACSF的组成(以mM计)是142mM NaCl,5mM KCl,2mM CaCl 2,2mM MgCl 2,1.25mM NaH 2 PO 4,10mM d-葡萄糖,10mM HEPES和0.05%不含脂肪酸的牛血清白蛋白( pH 7.4)。腹膜内(ip)注射药物的体积为0.1mL / 10g体重。当静脉内(iv)给药时,将溶液以0.1mL / 10g体重的体积注入尾静脉。将小鼠的头部放入塑料帽中,用一只手握住身体进行鞘内注射。将连接到Hamilton微量注射器的27号针头插入有意识的小鼠的L5和L6椎骨之间的蛛网膜下腔,并缓慢注射5mL药物溶液[1]。 |
| 参考文献 |
| 沸点 | 531.4ºC at 760 mmHg |
|---|---|
| 分子式 | C22H26ClNO2 |
| 分子量 | 371.90000 |
| 闪点 | 275.2ºC |
| 精确质量 | 371.16500 |
| PSA | 40.54000 |
| LogP | 5.04490 |
| InChIKey | SNGGBKYQZVAQKA-UHFFFAOYSA-N |
| SMILES | Cl.O=C(O)C1CCCN(CCC=C(c2ccccc2)c2ccccc2)C1 |
| 储存条件 | 2-8℃ |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
| 海关编码 | 2933399090 |
| SKF89976A盐酸盐上游产品 1 | |
|---|---|
| SKF89976A盐酸盐下游产品 0 | |
| 海关编码 | 2933399090 |
|---|---|
| 中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Age-dependent changes in the susceptibility to thiopental anesthesia in mice: analysis of the relationship to the functional expression of GABA transporter.
Pharmacol. Biochem. Behav. 103(2) , 267-72, (2012) The potency of anesthetics changes during development, probably due not only to pharmacokinetic factors such as differential distribution and/or metabolism, but also to pharmacodynamic factors such as... |
|
|
Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels.
Epilepsia 47 , 706-716, (2006) Stiripentol (STP) is currently an efficient drug for add-on therapy in infantile epilepsies because it improves the efficacy of antiepileptic drugs (AEDs) through its potent inhibition of liver cytoch... |
|
|
Selective gating of glutamatergic inputs to excitatory neurons of amygdala by presynaptic GABAb receptor.
Neuron 61(6) , 917-29, (2009) GABAb receptor (GABAbR)-mediated suppression of glutamate release is critical for limiting glutamatergic transmission across the central nervous system (CNS). Here we show that, upon tetanic stimulati... |
|
实验名称:Primary cell-based high-throughput screening assay for identification of compounds th...
来源:Johns Hopkins Ion Channel Center
靶标:regulator of G-protein signaling 4 isoform 2 [Homo sapiens]
External Id:JHICC_RGS_Act_HTS
|
|
实验名称:qHTS to identify inhibitors of the New Delhi Metallo-beta-lactamase (NDM): assay vali...
来源:NCGC
External Id:adst_MBL_Abs_LOPAC_o1
|
|
实验名称:Luminescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id:OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
|
|
实验名称:QFRET-based biochemical primary high throughput screening assay to identify exosite i...
来源:The Scripps Research Institute Molecular Screening Center
靶标:disintegrin and metalloproteinase domain-containing protein 17 preproprotein [Homo sapiens]
External Id:ADAM17_INH_QFRET_1536_1X%INH PRUN
|
|
实验名称:Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay
来源:ChEMBL
靶标:N/A
External Id:CHEMBL1266185
|
|
实验名称:In vitro inhibition of [3H]GABA uptake in rat synaptosomes
来源:ChEMBL
靶标:N/A
External Id:CHEMBL784482
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:uHTS identification of small molecule activators of the adaptive arm of the Unfolded ...
来源:Burnham Center for Chemical Genomics
靶标:N/A
External Id:BCCG-A405-UPR-XBP1-PrimaryAgonist-Assay
|
|
实验名称:Rescue cell viability in cybrid cells with a genetic mutation in complex 1 of the mit...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:N/A
External Id:HMS1315
|
|
实验名称:Fluorescence polarization to screen for inhibitor that competite the binding of FadD2...
来源:Broad Institute
靶标:FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE)
External Id:2147-01_Inhibitor_SinglePoint_HTS_Activity
|
| S1589_Selleck |
| 1-(4,4-Diphenylbut-3-en-1-yl)piperidine-3-carboxylic acid hydrochloride (1:1) |
| 1-(4,4-Diphenyl-3-buten-1-yl)-3-piperidinecarboxylic acid hydrochloride (1:1) |
| 3-Piperidinecarboxylic acid, 1-(4,4-diphenyl-3-buten-1-yl)-, hydrochloride (1:1) |
| SKF 89976A |
| SKF89976A (hydrochloride) |
| 1-(4,4-diphenyl-3-butenyl)-3-piperidinecarboxylicacidhydrochloride;SKF89976AHCl |